A phase 3 study of chemotherapy 1 pembrolizumab versus chemotherapy 1 placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590-Trial in progress

Yazar
Bhagia, P.
Zhu, Y.
Shah, S.
Doi, T.
Ozguroglu, M.
Kato, K.
Shah, M.
Enzinger, P.
Bennouna, J.
Shen, L.
Adenis, A.
Sun, J.
Cho, B.
Kojima, K.
Kostorov, V.
Hierro, C.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/118673
Koleksiyonlar